Investors had every reason to suspect today's news from Sagimet Biosciences (SGMT +44.88%) was coming sooner or later.

Shares of Arm Holdings (ARM 8.61%) were pulling back one session after surging in sympathy with a strong earnings report from ...

Kailera Therapeutics, a clinical-stage biotech focused on obesity treatments, just reported a notable insider buy in recent ...

The First Eagle Overseas Equity ETF (FEOE) takes a selective approach to international investing, focusing on companies ...

Diversifying a portfolio from a geographical perspective is probably something many investors aren't thinking about.

Core Natural Resources is a U.S.-based coal producer with integrated mining and export operations serving domestic and global ...

The first quarter of 2026 was an important and exciting period for Fulcrum highlighted by the positive clinical data we ...

Poet Technologies ( POET 44.91%) stock imploded this morning, falling 44% through 11:15 a.m. on reports of a feud between the ...

A Roth conversion could help you avoid required minimum distributions in retirement. Before you move funds into a Roth, make ...

Why Marvell's mad at Poet. Seems somebody let the cat out of the bag too soon, and Marvell is not happy about it. As Poet ...

Investors have grown excited about Revolution Medicines due to its promising pancreatic cancer drug, daraxonrasib.

Although Amazon has become something of a Swiss Army knife, its two core businesses continue to grow stronger and lead the ...